Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19088642 | 0.80 | TAS1R3 (0.36) | SCN9A | |
| SCHEMBL19088625 | 0.78 | CA2 (0.37) | MMP8CTSL | |
| SCHEMBL23693345 | 0.75 | MMP8 (0.41) | MMP8 | |
| SCHEMBL20166210 | 0.75 | MMP8 (0.41) | MMP8 | |
| SCHEMBL18256483 | 0.73 | CTSS (0.42) | CTSL | |
| SCHEMBL22502813 | 0.71 | TDP1 (0.38) | — | |
| SCHEMBL23279562 | 0.70 | CTSS (0.38) | MMP8CTSL | |
| SCHEMBL20166237 | 0.70 | CTSL (0.36) | CTSL | |
| SCHEMBL18248048 | 0.70 | CTSL (0.36) | CTSL | |
| SCHEMBL20166234 | 0.70 | CTSL (0.36) | CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220098241-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220098241-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | SCN9A 3594/4885MMP8 735/4885CTSL 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.